Lynx1 Capital Management LP
Top Portfolio Positions
22 positions ·
$783,926,820 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GHRS |
GH Research PLC
Healthcare
|
21,526,576 | $302,663,658 | 38.61% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
4,763,673 | $155,105,192 | 19.79% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
8,963,500 | $127,371,335 | 16.25% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
2,611,568 | $88,349,345 | 11.27% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
1,880,303 | $36,101,817 | 4.61% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
6,998,902 | $18,407,112 | 2.35% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
1,538,296 | $17,413,510 | 2.22% | |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
8,019,148 | $8,099,339 | 1.03% | |
| XNCR |
Xencor Inc
Healthcare
|
536,398 | $6,468,959 | 0.83% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
985,113 | $5,418,121 | 0.69% |
Portfolio Trend
18 quarters · across all stocks
Holdings in CCCC
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,407,112 | 6,998,902 | Shares | Other | 2026-05-04 | |
| 2025-12-31 | $13,557,434 | 7,098,133 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $15,757,855 | 7,098,133 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $10,150,330 | 7,098,133 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $11,357,012 | 7,098,133 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $24,669,878 | 6,852,744 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $39,219,003 | 6,880,527 | Shares | Other | 2024-11-14 | |
| 2023-12-31 | $17,709,337 | 3,134,396 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,895,767 | 1,019,230 | Shares | Other | 2023-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||